Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Miguel Martí-Cabrera"'
Autor:
Miguel Martí-Cabrera, Miguel Marti-Masanet, César Ríos-Navarro, Miriam Polo Peñalver, Juan Vicente Esplugues MotaI
Publikováno v:
Revista Cubana de Investigaciones Biomédicas, Vol 32, Iss 4, Pp 431-444
Antecedentes: la asociación entre los inhibidores de la bomba de protones (IBP) y el riesgo de osteoporosis y fracturas óseas es un tema que ha originado, recientemente, bastante interés en la literatura médica. Los IBP son los fármacos de prime
Externí odkaz:
https://doaj.org/article/9277e30b16a14fbab82b2efe9c911f87
Publikováno v:
Antioxidants
Antioxidants, Vol 9, Iss 848, p 848 (2020)
Antioxidants, Vol 9, Iss 848, p 848 (2020)
The rising prevalence of obesity and type 2 diabetes (T2D) is a growing concern worldwide. New discoveries in the field of metagenomics and clinical research have revealed that the gut microbiota plays a key role in these metabolic disorders. The mec
Autor:
Juan V. Esplugues, Miguel Martí-Cabrera, Pilar Codoñer-Franch, Ángeles Álvarez, Miguel Marti-Masanet, Samuel Orden
Publikováno v:
The Journal of Pediatrics. 221:181-187.e1
Objective To study leukocyte–endothelium interaction, a measure of the initial phase of atheromatosis, in children with overweight or obesity. Study design A prospective study was conducted in 77 children aged 7-16 years; 47 were children with over
Autor:
Samuel Orden, Miguel Martí-Cabrera, Ángeles Álvarez, Juan V. Esplugues, Carmen de Pablo, Sara Calatayud
Publikováno v:
Antiviral Therapy. 17:1615-1619
Background The association of abacavir (ABC) with cardiovascular disease has led to HIV treatment guidelines favouring the combination of tenofovir/emtricitabine (TDF/FTC) over that of ABC/lamivudine (ABC/3TC). We have analysed the effects of plasma-
Autor:
Miguel Martí-Cabrera, L.J. Gómez-Sucerquia, Ana Blas-Garcia, Nadezda Apostolova, Juan V. Esplugues
Publikováno v:
Antiviral Research. 94:232-241
Hepatic toxicity and metabolic disorders are major adverse effects elicited during the pharmacological treatment of the human immunodeficiency virus (HIV) infection. Efavirenz (EFV), the most widely used non-nucleoside reverse transcriptase inhibitor
Publikováno v:
Gastroenterología y Hepatología. 34:271-277
Proton pump inhibitors (PPI) are one of the most widely used groups of drugs and their potential toxicity is periodically reviewed, emphasizing aspects originally considered secondary. The present review analyzes the physiological and pharmacological
Publikováno v:
Current Drug Metabolism. 11:839-849
The vaginal route of drug administration provides women with a valid alternative to more conventional methods of contraception. Drugs absorbed in the upper part of the vagina can bypass the liver and, if metabolized, are subject to a reduced hepatic
Publikováno v:
Gastroenterología y Hepatología. 33:15-21
Resumen Los IBP han demostrado ser farmacos relativamente seguros despues de muchos anos de una amplia utilizacion. Las reacciones adversas con las que mas frecuentemente se han asociado son leves y con escasa repercusion clinica. Inducen hipergastri
Publikováno v:
Medicina Clínica. 127:790-795
La importante capacidad inhibitoria de la secrecion acida gastrica de los inhibidores de la bomba de protones (IBP) los convierte en los farmacos de eleccion en las enfermedades relacionadas con el acido. La elevada prevalencia de esas enfermedades y
Autor:
Esteban J. Morcillo, Julio Cortijo, L. Bruseghini, de la AsunciónFederico V Pallardó, José Luis García, A. Esteras, Jose Viña, Miguel Martí-Cabrera
Publikováno v:
Free Radical Biology and Medicine. 27:392-400
We examined the in vitro effects of tert-butylhydroperoxide (tBu-OOH) in human bronchial muscle. tert-Butylhydroperoxide produced concentration-dependent contractions of bronchial rings (maximum effect was 56.5 +/- 9.6% of contraction by 1 mM acetylc